Reversible melphalan-induced lung damage
Authors:
- Byron T. WesterfieldBWByron T. Westerfield
- Joseph P. MichalskiJMJoseph P. Michalski
- Candace MccombsCMCandace Mccombs
- Richard W. LightRLRichard W. Light
- 1 May 1980
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 68 (5) , 767-771
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibitory Activity of Unstimulated Alveolar Macrophages on T-Lymphocyte Blastogenic ResponseAmerican Review of Respiratory Disease, 1978
- Pulmonary disease with chlorambucil therapyCancer, 1978
- Decreased lymphocyte reactivity to a suboptimal concentration of phytohemagglutinin in sjögren's syndromeArthritis & Rheumatism, 1977
- Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer, 1976
- METHOTREXATE-INDUCED PNEUMONITISMedicine, 1976
- Phase II evaluation of bleomycin.A Southwest Oncology Group studyCancer, 1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- The Spectrum of Drug-Induced Pulmonary DiseaseAnnals of Internal Medicine, 1972
- Pulmonary fibrosis following therapy with Melphalan for multiple myelomaJournal of Clinical Pathology, 1972
- Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reactionCancer, 1972